<div class="headers"><div></div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>1(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='text-align: left;'>1</td>
<td style='text-align: left;'>1</td>
<td style='text-align: left;'><p class="">SpeciÔ¨Åc subgroup analyses were also performed.</p></td>
</tr>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>2</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>2</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p class="">Among patients with unstable angina, the incidence of primary endpoint was 3.8% in clopidogrel patients and 7.5% in ticlopidine patients (P % 0.04); among patients with stable angina, the incidence of primary endpoint was 4.9% in clopidogrel patients and 6.3% in ticlopidine patients (P % 0.32). </p></td>
</tr>
</tbody>
</table>
